BlackRock

BlackRock

BlackRock, Inc. is a leading American multinational investment company, recognized as the world's largest asset manager with over $12.5 trillion in assets under management. Founded in 1988, BlackRock initially focused on enterprise risk management and fixed income institutional asset management. The firm is headquartered in New York City and operates globally with 70 offices across 30 countries, serving clients in 100 countries. BlackRock is known for its commitment to innovative investment strategies and risk management, which have positioned it as a trusted partner in the financial markets. The firm employs a diverse investment approach, with significant emphasis on technology, healthcare, and industrial sectors. As part of its strategy, BlackRock actively manages a substantial portfolio through SEC 13F filings, reflecting a dynamic trading record characterized by position increases, reductions, and exits. The latest disclosures reveal a trading range of $227.5 billion to $247.7 billion, with notable activity in stocks such as NVIDIA Corporation (NVDA), Apple Inc (AAPL), and Microsoft Corp (MSFT). A significant move was recorded on August 13, 2024, when BlackRock added approximately $62.2 billion in NVIDIA, underscoring its strategic focus on technology investments.

Data sources and methodology

Latest Holdings

HoldingReported ValueWeightSharesLast PriceEst. ValueReturn
Alerus Financial CorporationALRS · Q2 2024$33M0.0%1.7M$28.90$49M+47.4%
Spirit Airlines, Inc.SAVE · Q2 2024$33M0.0%9.0M$1.08$9.7M-70.5%
464287390464287390 · Q2 2024$33M0.0%1.3M------
EyePoint Pharmaceuticals, Inc.EYPT · Q2 2024$33M0.0%3.8M$13.16$50M+51.3%
iShares Russell 2000 Value ETFIWN · Q2 2024$33M0.0%215k$214.82$46M+41.1%
MediaAlpha, Inc.MAX · Q2 2024$33M0.0%2.5M$8.64$21M-34.4%
2.9975E+1132.9975E+113 · Q2 2024$33M0.0%6.7M------
0076CA1040076CA104 · Q2 2024$33M0.0%5.3M------
04013V10804013V108 · Q2 2024$33M0.0%4.9M------
69036R86369036R863 · Q2 2024$32M0.0%3.8M------
3.6831E+1123.6831E+112 · Q2 2024$32M0.0%3.3M------
The Shyft Group IncSHYF · Q2 2024$32M0.0%2.7M$12.54$34M+5.73%
Savara Inc.SVRA · Q2 2024$32M0.0%8.0M$5.21$42M+29.3%
Pacific Biosciences of California, Inc.PACB · Q2 2024$32M0.0%24M$1.56$37M+13.9%
83190L20883190L208 · Q2 2024$32M0.0%1.4M------
Verve Therapeutics, Inc.VERV · Q2 2024$32M0.0%6.6M$11.13$74M+128.1%
Annexon, Inc.ANNX · Q2 2024$32M0.0%6.6M$5.39$36M+10.00%
M7518J104M7518J104 · Q2 2024$32M0.0%821k------
Theravance Biopharma, Inc.TBPH · Q2 2024$32M0.0%3.8M$16.20$61M+91.1%
04635X10204635X102 · Q2 2024$32M0.0%3.5M------
Brookfield Business CorporationBBUC · Q2 2024$32M0.0%1.6M$33.37$52M+63.4%
MaxCyte, Inc.MXCT · Q2 2024$32M0.0%8.1M$1.18$9.6M-70.0%
Oil States International, Inc.OIS · Q2 2024$32M0.0%7.2M$8.39$60M+89.0%
Southern Missouri Bancorp, Inc.SMBC · Q2 2024$32M0.0%705k$69.20$49M+53.7%
G6964L206G6964L206 · Q2 2024$32M0.0%1.8M------
98423J10198423J101 · Q2 2024$31M0.0%3.8M------
Community Health Systems, Inc.CYH · Q2 2024$31M0.0%9.4M$2.76$26M-17.9%
OraSure Technologies, Inc.OSUR · Q2 2024$31M0.0%7.4M$3.98$29M-6.57%
04041L10604041L106 · Q2 2024$31M0.0%2.0M------
Genius Sports LimitedGENI · Q2 2024$31M0.0%5.7M$6.47$37M+18.7%
SandRidge Energy, Inc.SD · Q2 2024$31M0.0%2.4M$14.16$34M+9.51%
29664W10529664W105 · Q2 2024$31M0.0%14M------
4.6436E+2664.6436E+266 · Q2 2024$31M0.0%600k------
30292L10730292L107 · Q2 2024$31M0.0%1.1M------
9252870292528702 · Q2 2024$31M0.0%1.1M------
591520200591520200 · Q2 2024$31M0.0%3.0M------
Stantec Inc.STN · Q2 2024$31M0.0%368k$75.47$28M-9.67%
Applied Therapeutics, Inc.APLT · Q2 2024$31M0.0%6.6M$0.103$677k-97.8%
780153BQ4780153BQ4 · Q2 2024$31M0.0%9.5M------
46434V29046434V290 · Q2 2024$31M0.0%499k------
Sierra BancorpBSRR · Q2 2024$30M0.0%1.4M$40.86$56M+82.6%
Companhia de Saneamento Básico do Estado de São Paulo - SABESPSBS · Q2 2024$30M0.0%2.3M$5.72$13M-57.5%
46435G52446435G524 · Q2 2024$30M0.0%451k------
Nevro Corp.NVRO · Q2 2024$30M0.0%3.6M$5.84$21M-30.6%
HilleVax, Inc.HLVX · Q2 2024$30M0.0%2.1M$2.09$4.4M-85.5%
Atea Pharmaceuticals IncAVIR · Q2 2024$30M0.0%9.1M$4.55$41M+37.5%
92854T10092854T100 · Q2 2024$30M0.0%5.2M------
Phathom Pharmaceuticals, Inc.PHAT · Q2 2024$30M0.0%2.9M$10.00$29M-2.91%
Arcelor Mittal NY Registry Shares NEWMT · Q2 2024$30M0.0%1.3M$67.18$88M+193.0%
Telus Corporation Ordinary SharesTU · Q2 2024$30M0.0%2.0M$12.39$25M-18.2%
Showing 2651-2700 of 5227